TB Alliance

Share your videos with friends, family, and the world.

photo by John-Michael Maas for the TB Alliance (2021). Achievements. Consortium members have advanced several compounds into clinical studies and have been ...

U.S. FDA approves TB Alliance's treatment for drug-resistant ...

The U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug ...

Investing in the next generation of Tuberculosis treatment

Australia is supporting our region to end tuberculosis by investing $17 million in the Global Alliance for Tuberculosis (TB Alliance) to ...

Pipeline | Working Group for New TB Drugs

TB Alliance, ERA4TB (European Regimen Accelerator for Tuberculosis), University of Auckland, Merck & Co., Inc. ... Bill & Melinda Gates Medical Research Institute ...

TB Alliance Statement on New World Health Organization Rapid ...

Ukraine was the first country to conduct operational research on how the BPaL regimen performed in clinical practice settings. Its reported ...

Treatment for drug-resistant TB - MedAccess

Pretomanid (the Pa in BPaLM) was developed by the TB Alliance, which has granted non-exclusive licenses for high-burden, low- and middle-income countries to ...

About TB Alliance - GHIT Fund

• This provided a road map for Global Alliance for TB Drug Development (TB. Alliance). • We are a Product Development Partnership (PDP) and rely heavily on ...

TB Alliance - X

TB Alliance · @TBAlliance. Tuberculosis is a global pandemic, killing someone approximately every 20 seconds — about 1.3 million in 2022 alone.

TB Alliance | New York NY - Facebook

TB Alliance, New York, New York. 8686 likes · 5 talking about this · 3 were here. TB Alliance is a non-profit product development partnership working to...

Phase 2 trial of a novel tuberculosis drug launched - The Lancet

... tuberculosis with the same regimen,” said Mel Spigelman, President of the TB Alliance. Although tuberculosis is preventable and mostly ...

Promising new tuberculosis drug approved, but will it be affordable?

Separate clinical trials run by MSF and TB Alliance are underway to further evaluate pretomanid-containing regimens to try to identify safer ...

A Crucial Step for the TB Alliance NC-009 Study - THINK South Africa

NC-009 is a pan-Phase 2 clinical trial incorporating Phase 2a, b, and c elements. NC-009 aims to evaluate the safety and efficacy of a ...

TB Alliance - MPP - Medicines Patent Pool

TB Alliance. In April 2016, we signed a MoU with TB Alliance outlining a multi-pronged collaboration to encourage the development of new TB ...

TB Alliance: New TB Drug Approved to Treat the Deadliest Forms of ...

Pretomanid is the second drug approved for drug-resistant TB by the U.S. FDA in more than 40 years, and the first approved as part of a full ...

TB Alliance Drug,TBA-354, enters Phase I Clinical Trials

... tuberculosis and currently pretomanid is being tested in several clinical trials. To read the official press release from TB Alliance, click here.

Price reduction paves the way for expanded access to highly ...

Viatris, MedAccess, and TB Alliance announce a new agreement to reduce the price of pretomanid to treat multidrug-resistant TB by 34%.

TB Alliance (TB Alliance) | New York, NY - Cause IQ

TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are ...

TB Alliance – Annual Report – Blog - Going International

In 2015, TB Alliance and partners announced the launch of child-friendly tuberculosis medicines in the correct doses. The improved treatments are the first to ...

How TB Alliance's Mel Spigelman created a promising new anti ...

In August 2019, TB Alliance's pretomanid became one of three new anti-tuberculosis drugs approved by the FDA, and the first developed and ...